14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £2.01 £2.74 Thursday, 2nd May 2024 IMM.L stock ended at £2.04. This is 0.246% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.98% from a day low at £2.01 to a day high of £2.11.
90 days £0.82 £3.00
52 weeks £0.82 £3.80

Historical Immupharma Plc prices

Date Open High Low Close Volume
Mar 09, 2016 £26.75 £26.75 £26.25 £26.25 75 267
Mar 08, 2016 £26.75 £26.75 £26.75 £26.75 8 261
Mar 07, 2016 £27.00 £27.00 £26.75 £26.75 50 861
Mar 04, 2016 £26.25 £27.00 £26.25 £27.00 218 234
Mar 03, 2016 £25.75 £26.25 £25.75 £26.25 125 007
Mar 02, 2016 £25.50 £25.75 £25.50 £25.75 275 439
Mar 01, 2016 £24.75 £25.50 £24.75 £25.50 189 628
Feb 29, 2016 £23.50 £24.25 £23.50 £24.25 41 845
Feb 26, 2016 £23.50 £23.50 £23.50 £23.50 32 700
Feb 25, 2016 £23.50 £23.50 £23.50 £23.50 2 012
Feb 24, 2016 £24.00 £24.00 £23.00 £23.50 55 959
Feb 23, 2016 £24.00 £24.00 £24.00 £24.00 501 748
Feb 22, 2016 £24.00 £24.00 £24.00 £24.00 41 255
Feb 19, 2016 £23.75 £24.00 £23.75 £24.00 24 197
Feb 18, 2016 £24.75 £24.75 £23.75 £23.75 76 284
Feb 17, 2016 £24.75 £24.75 £24.50 £24.75 40 666
Feb 16, 2016 £23.50 £24.75 £23.50 £24.75 73 051
Feb 15, 2016 £24.50 £24.75 £23.50 £23.50 300 435
Feb 12, 2016 £24.38 £24.38 £24.38 £24.38 12 586
Feb 11, 2016 £24.38 £24.38 £24.38 £24.38 3 157
Feb 10, 2016 £24.25 £24.75 £23.75 £24.38 457 190
Feb 09, 2016 £26.25 £26.25 £24.25 £24.25 162 980
Feb 08, 2016 £25.50 £26.25 £25.50 £26.25 108 837
Feb 05, 2016 £28.50 £28.50 £25.50 £25.50 404 929
Feb 04, 2016 £28.75 £29.00 £28.75 £29.00 18 950
Click to get the best stock tips daily for free!

About Immupharma Plc

Immupharma Plc ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a... IMM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT